In trading on Wednesday, shares of Diebold, Inc. (DBD - Get Report) touched a new 52-week high of $35.96/share. That's a 30.34% rise, or $8.37 per share from the 52-week low of $27.59 set back on 03/06/2013. That means at today's intraday high, any investor who purchased DBD stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, DBD has seen 4 different instances of insiders buying over the trailing six month period.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
08/30/2013 Andreas W. Mattes President and CEO 1,000 $28.50 $28,500.00
09/09/2013 John D. Kristoff VP, Chief Communications Ofcr. 200 $29.16 $5,831.98
12/06/2013 Andreas W. Mattes President and CEO 500 $32.88 $16,438.10
12/11/2013 Sheila M. Rutt VP, Chief HR Officer 150 $31.85 $4,776.90
12/11/2013 Stefan Merz Sr. VP, Strategic Projects 300 $32.07 $9,622.26
12/11/2013 John D. Kristoff VP, Chief Communications Ofcr. 100 $31.67 $3,167.00

The chart below shows where DBD has traded over the past year, with the 50-day and 200-day moving averages included.

Diebold, Inc. Moving Averages Chart

In afternoon trading on Wednesday, DBD shares are changing hands at $35.75/share, slightly below the new 52-week high.